Climb Bio, Inc. (CLYM)
5.67
+0.40
(+7.59%)
USD |
NASDAQ |
Feb 13, 16:00
5.68
+0.01
(+0.18%)
After-Hours: 20:00
Climb Bio Market Cap : 386.61M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 124.83B |
| Fortress Biotech, Inc. | 112.05M |
| Oramed Pharmaceuticals, Inc. | 129.36M |
| Lyell Immunopharma, Inc. | 382.64M |
| PepGen Inc. | 442.74M |
Market Cap Related Metrics
| Price to Book Value | 2.184 |
| Price | 5.67 |
| Earnings Yield | -13.24% |